Cargando…

Additional Drug Resistance in Patients with Multidrug-resistant Tuberculosis in Korea: a Multicenter Study from 2010 to 2019

BACKGROUND: Drug-resistance surveillance (DRS) data provide key information for building an effective treatment regimen in patients with multidrug-resistant tuberculosis (MDR-TB). This study was conducted to investigate the patterns and trends of additional drug resistance in MDR-TB patients in Sout...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Taehoon, Lee, Seung Jun, Jeon, Doosoo, Lee, Ho Young, Kim, Hyo-Jung, Kang, Bo Hyoung, Mok, Jeongha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258238/ https://www.ncbi.nlm.nih.gov/pubmed/34227261 http://dx.doi.org/10.3346/jkms.2021.36.e174

Ejemplares similares

Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design
por: Mok, Jeong Ha, et al.
Publicado: (2017)

Trend of multidrug and fluoroquinolone resistance in Mycobacterium tuberculosis isolates from 2010 to 2014 in Korea: a multicenter study
por: Kim, Hyeonseok, et al.
Publicado: (2019)

Time to appropriate treatment in patients with multidrug-resistant tuberculosis in South Korea: Are we still in 2010?
por: Jo, Eun-Jung, et al.
Publicado: (2019)

Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011–2017: A Retrospective Cohort Study (Korean TB-POST)
por: Choi, Hongjo, et al.
Publicado: (2023)

Retreatment after loss to follow-up reduces mortality in patients with multidrug/rifampicin-resistant tuberculosis
por: Choi, Hongjo, et al.
Publicado: (2023)

Impact of Anti-Tuberculosis Drug Use on Treatment Outcomes in Patients with Pulmonary Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: A Nationwide Retrospective Cohort Study with Propensity Score Matching
por: Choi, Hongjo, et al.
Publicado: (2023)

Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply
por: Kang, Yewon, et al.
Publicado: (2022)

Linezolid-induced black hairy tongue in a patient with multidrug-resistant tuberculosis: A case report
por: Lee, Jaemin, et al.
Publicado: (2021)

WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea
por: Jeon, Doosoo
Publicado: (2017)

A prospective patient registry to monitor safety, effectiveness, and utilisation of bedaquiline in patients with multidrug-resistant tuberculosis in South Korea
por: Shim, Tae Sun, et al.
Publicado: (2023)

Medical Management of Drug-Resistant Tuberculosis
por: Jeon, Doosoo
Publicado: (2015)

The Growing Problem of Multidrug-Resistant Tuberculosis in North Korea
por: Seung, Kwonjune J., et al.
Publicado: (2013)

Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Comparison of Pre- and Post-Public–Private Mix Periods
por: Kang, Yewon, et al.
Publicado: (2021)

Multidrug-Resistant Tuberculosis, Somalia, 2010–2011
por: Sindani, Ireneaus, et al.
Publicado: (2013)

Multidrug-Resistant Tuberculosis in Europe, 2010–2011
por: Günther, Gunar, et al.
Publicado: (2015)

Impact of Molecular Drug Susceptibility Testing on the Time to Multidrug-resistant Tuberculosis Treatment Initiation
por: Jeon, Doosoo, et al.
Publicado: (2020)

Prevalence and associated factors of diabetes mellitus among patients with tuberculosis in South Korea from 2011 to 2018: a nationwide cohort study
por: Jeong, Dawoon, et al.
Publicado: (2023)

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
por: Lee, Myungsun, et al.
Publicado: (2019)

Latent tuberculosis infection: recent progress and challenges in South Korea
por: Jeon, Doosoo
Publicado: (2020)

Clinical efficacy of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in patients with multidrug-resistant bacteremia: a single-center study in Korea
por: Mok, Jeongha, et al.
Publicado: (2019)

Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible?
por: Seung, Kwonjune J., et al.
Publicado: (2016)

Comparison of Disability-Adjusted Life Years (DALYs) and Economic Burden on People With Drug-Susceptible Tuberculosis and Multidrug-Resistant Tuberculosis in Korea
por: Lee, SeungCheor, et al.
Publicado: (2022)

Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria
por: Lee, Hyo-Jin, et al.
Publicado: (2022)

High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010
por: Sanchez-Padilla, Elisabeth, et al.
Publicado: (2012)

Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea
por: Yang, Jeong Seong, et al.
Publicado: (2018)

Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries
por: Kurbatova, Ekaterina V., et al.
Publicado: (2015)

Fluoroquinolone resistance in multidrug-resistant tuberculosis patients
por: Lee, Hyun-Woo, et al.
Publicado: (2019)

Drug Resistance Patterns of Multidrug- and Extensively Drug-Resistant Tuberculosis in Korea: Amplification of Resistance to Oral Second-line Drugs
por: Kim, Chang-Ki, et al.
Publicado: (2017)

Protocol of a Nationwide Observational Study among Patients with Nontuberculous Mycobacterium Pulmonary Disease in South Korea (NTM-KOREA)
por: Kwak, Nakwon, et al.
Publicado: (2020)

Age-stratified anti-tuberculosis drug resistance profiles in South Korea: a multicenter retrospective study
por: Lee, Eung Gu, et al.
Publicado: (2020)

Is Multi-Drug Resistant Tuberculosis More Prevalent in HIV-Infected Patients in Korea?
por: Lee, Shinwon, et al.
Publicado: (2016)

Treatment outcomes and factors affecting treatment outcomes of new patients with tuberculosis in Busan, South Korea: a retrospective study of a citywide registry, 2014–2015
por: Mok, Jeongha, et al.
Publicado: (2018)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Multidrug-resistant tuberculosis
por: Lemos, Antônio Carlos Moreira, et al.
Publicado: (2013)

Antibiogram of Multidrug-Resistant Bacteria Based on Sepsis Onset Location in Korea: A Multicenter Cohort Study
por: Kim, Hyung-Jun, et al.
Publicado: (2023)

Import of multidrug-resistant bacteria from abroad through interhospital transfers, Finland, 2010–2019
por: Kajova, Mikael, et al.
Publicado: (2021)

Prevalence of Multidrug-Resistant Tuberculosis in HIV/Tuberculosis Co-Infected Patients
por: Lee, Chan Mi, et al.
Publicado: (2021)

Treatment Outcome and Mortality among Patients with Multidrug-resistant Tuberculosis in Tuberculosis Hospitals of the Public Sector
por: Jeon, Doo Soo, et al.
Publicado: (2011)

Implications of Radiotherapy Utilization in Korea from 2010 to 2019
por: Lee, Jeongshim, et al.
Publicado: (2021)

Multidrug-Resistant Corynebacterium striatum Bacteremia: First Case in Korea
por: Yoo, Gilsung, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7ib5blouekfin7brhiaaa4rjuq